Register now: https://cffutures.zoom.us/webinar/register/WN_gkekmPiFTy29vluRyZ1R0Q#/registration
Tuesday, June 13, 2023, 3 - 4 p.m. ET
Tuesday, June 20, 2023, 3 - 4 p.m. ET
Join these webinars to engage with national experts to learn more about
• Our understanding (past and present) of the effects of prenatal alcohol exposure on neurodevelopment
• Developmental and behavioral manifestations of prenatal alcohol-related brain injury across childhood and adolescence
• Similarities and differences related to other neurodevelopmental disorders, such as autism and attention-deficit/hyperactivity disorder (ADHD)
• Screening for prenatal alcohol exposure and barriers to diagnosing fetal alcohol spectrum disorder
• Interventions across the lifespan
Presenter: Douglas Waite, M.D., FAAP
Douglas Waite, M.D., FAAP, is Division Chief of Developmental and Behavioral Pediatrics at BronxCare Health System. Dr. Waite holds an appointment of Assistant Clinical Professor of Pediatrics at Mount Sinai Hospital and is a member of the executive committee of the American Academy of Pediatrics (AAP) Council on Foster Care, Adoption, and Kinship Care. He has worked with AAP at the national and state levels on raising awareness of the neurodevelopmental effects of prenatal alcohol and substance exposure and is a participant in two panels formed by the AAP, Centers for Disease Control and Prevention, and U.S. Administration for Children and Families to develop protocols for screening children in child welfare and the general pediatric population for fetal alcohol and drug exposure. Dr. Waite has special interests in FASD, post-traumatic stress disorder, and the effects of child abuse and neglect on child development.
The second session (a dialogue with Dr. Waite) serves as an opportunity to share your ideas and experiences; it’s also a great chance to ask questions! Please submit your questions to presenters when you register for the sessions. Registration is for both sessions.
English